A
ANRO icon

AlphaQuest’s Alto Neuroscience ANRO Stock Holding History

AlphaQuest’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,821
Closed -$68K – 2162
2025
Q4 		$68K Buy
+3,821
New +$48.1K ﹤0.01% 1863

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AlphaQuest's ANRO Position: Q1 2026 in Review

AlphaQuest sold out of Alto Neuroscience (ANRO) in Q1 2026, closing a stake of 3,821 shares — an estimated $68K sold.

AlphaQuest first reported a position in ANRO in Q4 2025 and held it in 1 quarter. The position peaked at $68K in Q4 2025. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • AlphaQuest reported no remaining Alto Neuroscience position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 3,821 Alto Neuroscience shares in Q1 2026, an estimated $68K.
  • AlphaQuest first reported a position in Alto Neuroscience in Q4 2025 and held it in 1 quarter.
  • AlphaQuest's Alto Neuroscience position peaked at $68K in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.